Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs148158907 | chr8:135504274 | G/GT | 0.000236 | 173 | 20.2 | 25.6 | 28.95 | KM Plot |
PCPG | rs148214594 | chr2:24322341 | G/A | 0.000122 | 175 | 25.4 | 27.52 | 17.43 | KM Plot |
PCPG | rs148222551 | chr2:242518759 | AAAAG/A | 4.19E-11 | 178 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs148465642 | chr9:36133777 | AT/A | 0 | 170 | 25.53 | 30.67 | 2.93 | KM Plot |
PCPG | rs148518934 | chr2:118573983 | TTTTTA/T | 1.92E-5 | 176 | 25.17 | 25.97 | 11.65 | KM Plot |
PCPG | rs148605139 | chr12:56684657 | CA/C | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs148716715 | chr21:38483354 | G/A | 1.07E-8 | 174 | 25.35 | 25.63 | 3.83 | KM Plot |
PCPG | rs148722891 | chr7:105154771 | G/T | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs148804868 | chr16:89817203 | C/CA | 0.000183 | 175 | 26.57 | 20.17 | 36.37 | KM Plot |
PCPG | rs148874097 | chr12:56747744 | C/T | 9.85E-8 | 177 | 25.35 | 27.33 | 9.98 | KM Plot |
PCPG | rs148917111 | chr13:37626679 | AC/A | 0.000308 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs148961925 | chr2:118549549 | TTTTC/T | 1.73E-5 | 177 | 25 | 34.35 | 11.65 | KM Plot |
PCPG | rs149024843 | chr2:24321673 | G/A | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs149120386 | chr3:195732463 | C/G | 1.24E-5 | 177 | 24.52 | 31.47 | 13.38 | KM Plot |
PCPG | rs149125341 | chr7:1105893 | G/GACGATC | 0.000262 | 173 | 25.87 | 24.95 | 49.58 | KM Plot |